G01N 2333/485
Epidermal growth factor [egf]
Official title: Epidermal growth factor [EGF] (urogastrone)
G01N2333/485 (Epidermal growth factor [egf]) appears on 142 US grants and 280 published applications in this corpus.
Search patents in G01N- Granted patents
- 142
- Published applications
- 280
- Assignees
- 137
- Inventors
- 519
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 1 |
| 2002 | 3 | 1 |
| 2003 | 2 | 63 |
| 2004 | 4 | 10 |
| 2005 | 6 | 5 |
| 2006 | 7 | 5 |
| 2007 | 6 | 6 |
| 2008 | 2 | 12 |
| 2009 | 6 | 9 |
| 2010 | 4 | 15 |
| 2011 | 4 | 9 |
| 2012 | 6 | 12 |
| 2013 | 5 | 11 |
| 2014 | 4 | 14 |
| 2015 | 8 | 15 |
| 2016 | 8 | 17 |
| 2017 | 6 | 19 |
| 2018 | 14 | 7 |
| 2019 | 4 | 4 |
| 2020 | 11 | 9 |
| 2021 | 3 | 9 |
| 2022 | 3 | 7 |
| 2023 | 2 | 6 |
| 2024 | 3 | 6 |
| 2025 | 4 | 4 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds and methods targeting epiregulin14 Apr 2026US 12,600,767 B2Eli Lilly and Company
- Methods of detecting and treating cerebral aneurysms17 Feb 2026US 12,553,904 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulin23 Sep 2025US 12,419,201 B2Ventana Medical Systems, Inc.
- Weeding mechanism and a weeding vehicle including the weeding mechanism23 Sep 2025US 12,422,436 B2Ekobot AB
- Monoclonal antibody specifically binding to CCSP-2 and use thereof18 Feb 2025US 12,227,592 B2Edisbiotech Co., Ltd.
- Compositions and Methods for Treating Metastatic Cancer23 Jul 2026US 2026/0207743 A1
- Systemic biomarkers for the dynamic assessment of tumor burden and treatment efficacy in high grade gliomas2 Jul 2026US 2026/0188489 A1Mary Hitchcock Memorial Hospital, for itself and on behalf of Dartmouth-Hitchcock Clinic
- Methods of detecting and treating cerebral aneurysms19 Feb 2026US 2026/0049998 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Compositions and methods for analysis, detection, and treatment of multiple sclerosis22 Jan 2026US 2026/0023085 A1The Regents of the University of Michigan
- Methods of detecting and treating cerebral aneurysms13 Nov 2025US 2025/0347700 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
Most cited
By later US patents
- Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments172US 7,294,468 B2Dana-Farber Cancer Institute, Inc. · 2007
- Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers133US 7,198,899 B2Chiron Corporation · 2007
- Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers133US 7,476,506 B2Novartis Vaccines and Diagnostics, Inc. · 2009
- Cell analysis method using quantitative fluorescence image analysis104US 5,733,721 AThe Board of Regents of the University of Oklahoma · 1998
- Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments99US 8,105,769 B2Dana-Farber Cancer Institute, Inc. · 2012